Alan Mast Knows Firsthand How Far Blood Research Has Come
Versiti Blood Research Institute posted on LinkedIn:
”Alan Mast, MD, PhD, knows firsthand how far blood research has come. When his daughter developed a blood clot in her brain, he reflected on the power of progress: “50 years ago, she would have only had a 70% chance of survival. 30 years ago, she would have been in the hospital for two weeks, receiving intravenous solutions. Now she’s able to be treated as an outpatient with a pill.”
Today, Dr. Mast’s lab investigates Tissue Factor Pathway Inhibitor (TFPI), a protein that helps prevent clot formation. By studying how TFPI interacts with blood vessels and platelets, his team is advancing understanding of bleeding and clotting disorders—and helping bring precision medicine into vascular diagnostics.
Read the case study to learn more.”
Keep up with Hemostasis Today.
-
Nov 19, 2025, 18:03Andres Ricaurte Fajardo on a Strongyloides Stercoralis Hyperinfection with Thrombosis
-
Nov 19, 2025, 17:50Marilena Vrana Reflects on PPTA Europe’s Visits with Members and Stakeholders in 2025
-
Nov 19, 2025, 17:32Michael Makris Shares Insights from Global Forum Meeting of the WFH Meeting in Montreal
-
Nov 19, 2025, 17:14Yazan Abou Ismail Takes The Legacy Award from Qatar Foundation
-
Nov 19, 2025, 17:02Wolfgang Miesbach Shares Real-World Evidence on Eptacog Beta from Spain
-
Nov 19, 2025, 16:34Ishita Singh Reflects on Haematocon 2025: A Reminder of Her Commitment to The Journey
-
Nov 19, 2025, 16:23Mehdi Kashani: I’m Really Excited to Share Schistosite.com
-
Nov 19, 2025, 16:09A ”Meow-cyte” from Melaku Abay Muluneh or Why Microscopy Never Gets Old!
-
Nov 19, 2025, 15:56Cuilan Li on her Contribution to a Cutting-Edge Project in Polycythemia Vera